DermTech, Inc. Banner Image

DermTech, Inc.

  • Ticker DMTK
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
DermTech, Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by their non-invasive skin genomics platform. DermTech’s mission is to transform the practice of dermatology through more accurate diagnosis and treatment, and the elimination of unnecessary surgery, leading to improved patient care and lower costs. DermTechMore provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments.
4.8 / 5.0 (188)

DermTech, Inc. reports have an aggregate usefulness score of 4.8 based on 188 reviews.

DermTech, Inc.

Most Recent Annual Report

DermTech, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

DermTech, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!